Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00019071 · ClinicalTrials.gov registry record · Phase 1
Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00019071: Completed Phase 1 study, sponsored by National Cancer Institute (NCI).
NCT00019071 is a Phase 1 study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00019071, a Phase 1 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cladribine followed by radiation therapy in treating patients who have malignant glioma.
Interventions
- RADIATION radiation therapy
- DRUG chemotherapy
- DRUG cladribine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1995-03 |
| Phase | Phase 1 |
What the finished NCT00019071 record still lists
NCT00019071 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which radiation therapy is the first listed.
NCT00019071 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00019071 about?
NCT00019071 is a clinical study titled "Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effec...
What is the current status of trial NCT00019071?
This trial is currently completed. It is a Phase 1 study. The study started on 1995-03.
What interventions are being tested in trial NCT00019071?
The interventions under investigation include: radiation therapy (RADIATION), chemotherapy (DRUG), cladribine (DRUG).
Who is sponsoring clinical trial NCT00019071?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia